Given that NOD1 synthetic agonists can restore NOD1-mediated host protective functions in CsA-treated mice[47], the administration of synthetic NOD1 agonists alone or in combination with antibiotics might be potentially helpful to reduce the occurrence of ascending UTI and APN in renal graft. Here, NOD1 is linked to bacterial urinary tract infection.